Daily non-political popular news in brief.

Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs

09-29-2006 · ScienceDaily

In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."

Keywords: gene, signatures, match, cancer, diseases, potentially, effective, drugs, signature, disease, drug

« Previous | Next »

Similar news on "Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs":

Gene expression profiling of dengue virus infection in cell lines and patients
11-06-2007 · EurekAlert!
Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease. The results suggest that drugs that target the host pathways may prove effective against dengue.
Similar news · Read more »
Enzyme structure reveals new drug targets for cancer and other diseases
02-14-2008 · EurekAlert!
Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
Similar news · Read more »
Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
06-27-2007 · EurekAlert!
Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
Similar news · Read more »
Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease
11-12-2007 · EurekAlert!
Molecular biologists at Jefferson's Kimmel Cancer Center in Philadelphia have detailed the cascade of cellular events behind some potentially dangerous autoinflammatory diseases. In doing so, they not only have gained a greater understanding of the disease process, but have also identified new potential drug targets for diseases ranging from arthritis to cancer.
Similar news · Read more »
Tequila raw ingredient being developed into drug-carrier that targets colon diseases
03-27-2007 · EurekAlert!
Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
Similar news · Read more »
Firefly genes allow testing of new therapy against lymphoma
12-19-2007 · EurekAlert!
Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
Similar news · Read more »
Modeling lung cancer
02-12-2007 · EurekAlert!
In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
Similar news · Read more »
New target for anti-flu drug development
08-15-2007 · EurekAlert!
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Mass., in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-flu drugs, including those that may be effective against potentially pandemic influenza strains like H5N1. The findings have been published in the Aug. 15, 2007, issue of the journal Cell Cycle. A figure from their paper was selected for the journal cover.
Similar news · Read more »
MIT model could predict cells' response to drugs
07-30-2007 · EurekAlert!
MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
Similar news · Read more »
MIT links gene to cholesterol
10-11-2007 · EurekAlert!
MIT researchers have discovered a link between a gene believed to promote long lifespan and a pathway that flushes cholesterol from the body. The finding could help researchers create drugs that lower the risk of diseases associated with high cholesterol, including atherosclerosis (clogged arteries) and Alzheimer's disease.
Similar news · Read more »